TCH346

TCH-346 · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TCH346, covering 2011-11-23 to 2011-11-24. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis (ALS) [Phase 2]

See pricing